The distributors and insurers claiming Merck & Co. led a scheme to delay generic competition for the cholesterol drug Zetia asked a Virginia federal judge to certify separate classes of purchasers and payers.

Planned Parenthood can’t appeal a decision rejecting its claim that new criteria for federal family planning grants are inconsistent with governing regulations and administrative rules because the government has already awarded the program funds, the District of Columbia Circuit said Nov. 19.

Medicines Co., the developer of a promising cholesterol drug, has attracted takeover interest from suitors including Novartis AG, people familiar with the matter said.

Patients alleging the University of Southern California did nothing to stop a doctor who sexually abused them at an on-campus medical clinic are urging a federal court in California to grant final approval to a $215 million class action settlement.

Juul Labs Inc. is being sued by New York for allegedly trampling state marketing laws by targeting teenagers in advertisements for e-cigarettes and making misleading statements about nicotine content in vaping products, among other things, the state’s top law enforcement officer said.

Sanofi lost its appeals court bid to revive two patents on the Lantus insulin drug, eliminating an obstacle to Mylan NV’s proposed insulin treatment.